The latest market insights highlight key developments impacting Hong Kong-listed stocks, from regulatory changes to corporate actions and earnings forecasts.

Regulatory Focus

China's National Medical Products Administration (NMPA) has released a draft announcement for public feedback, outlining measures to optimize the review and approval process for cell and gene therapy products. The proposal aims to encourage innovation and enhance the efficiency of clinical development. It specifically supports research and development in critical areas such as malignant tumors, rare diseases, genetic disorders, immune system diseases, and neurodegenerative diseases. A key provision is the plan to include eligible cell and gene therapy drugs in a fast-track 30-day review channel for clinical trial applications of innovative drugs, aiming to accelerate clinical development. This development is relevant for Hong Kong's innovative drug sector.

Market Overview

US stock markets were closed on Friday, July 3rd, in observance of the Independence Day holiday.

Key Developments to Watch

A draft amendment to China's E-commerce Law has been released for public consultation. Jointly drafted by the State Administration for Market Regulation and the Ministry of Commerce, the proposed changes aim to better protect the rights of all parties in e-commerce, further regulate the conduct of platform operators, and promote the sustainable and healthy development of the sector. This pertains to Hong Kong-listed e-commerce platform companies.

Faster Innovation Holdings Ltd (HK: 03355) announced it has entered into a share transfer agreement to acquire 100% of the equity in Shanghai Boda Data Communication Co., Ltd. for a total consideration of RMB 330 million.

CDB Financial Leasing Co., Ltd. (HK: 01606) disclosed a product procurement agreement to purchase information technology computer equipment for a total price not exceeding RMB 4 billion.

Gushengtang Health Technology Group Co., Ltd. (HK: 02273) stated that its subsidiary intends to acquire controlling stakes in Shahe Hospital and Beijing Hongyang Hospital. Following the completion of the acquisitions, both hospitals will become subsidiaries, and their financial results will be consolidated.

Chifeng Jilong Gold Mining Co., Ltd. (HK: 06693) announced a strategic investment agreement with Zijin Gold (Group) Co., Ltd. Under the agreement, Zijin Gold has conditionally agreed to subscribe for approximately 311 million H shares at HK$29.82 per share.

Smoore International Holdings Limited (HK: 06969) disclosed that EVE Battery, a shareholder holding approximately 30.25% of the company's issued shares, intends to further reduce its stake by 3.5%. EVE Battery is ultimately wholly-owned by EVE Energy Co., Ltd. Upon completion of the sale, EVE Battery will cease to be a controlling shareholder of Smoore.

Biren Technology (HK: 06082) announced a proposed placement of 153 million H shares, with an estimated net proceeds of approximately HK$7.038 billion. The funds are intended to accelerate the commercialization and production of next-generation products, strengthen R&D in new cutting-edge technology projects, facilitate strategic investments and acquisitions, and supplement working capital.

Ruifeng Power Group Limited (HK: 02025) provided an update on its strategic cooperation agreement for intelligent underwater cleaning and inspection robots. The group has recently commenced trial production of four ship-cleaning robots designed by its partner, with expected delivery to the customer in August 2026. Following acceptance, these robots will enter formal commercial operation and sales.

Innovation Industrial Ltd. (HK: 02788) issued a positive profit alert, expecting net profit for the interim period to be between approximately RMB 2.2 billion and RMB 2.4 billion, representing a year-on-year increase of about 154.1% to 177.2%. The significant increase is attributed to higher sales prices for electrolytic aluminum products, a higher proportion of green electricity usage reducing production costs, and optimized financing structure leading to lower financial costs.

Dongyue Group Limited (HK: 00189) announced that its subsidiary, Dongyue Silicon Material Co., Ltd., expects net profit attributable to shareholders for the first half of 2026 to be approximately RMB 424 million to RMB 444 million, a year-on-year increase of about 904.88% to 952.28%.

GTHT (HK: 02611) forecasted that net profit attributable to shareholders for the first half of 2026 is expected to be between RMB 20.003 billion and RMB 20.511 billion, representing a year-on-year increase of 27% to 30%.

Stock in Focus: GBA AI COMP (HK: 01396)

Amid explosive growth in demand for AI computing power, the group reported cumulative new AI computing power cloud service intention orders exceeding RMB 15 billion in the first half of 2026, corresponding to an AI computing power scale of approximately 35,000 PFLOPS (FP16 dense). As of June 30, 2026, newly delivered AI computing power cloud service orders amounted to over RMB 2 billion, with a corresponding newly delivered operational AI computing power scale of about 6,000 PFLOPS (FP16 dense). The group is actively constructing and delivering the remaining orders. It also expects interim net profit to be no less than RMB 240 million.